Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0LN9D
|
|||
Drug Name |
Cyano(dimethyl)methyl isoxazoles and [1,3,4]-thiadiazoles derivative 1
|
|||
Synonyms |
PMID27215781-Compound-14
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
|
|||
Structure |
Download2D MOL |
|||
Formula |
C18H28N4O3
|
|||
Canonical SMILES |
CC(C)(C#N)C1=NOC(=C1)NC(=O)C(C)(C)N(C)CC2CCOCC2
|
|||
InChI |
1S/C18H28N4O3/c1-17(2,12-19)14-10-15(25-21-14)20-16(23)18(3,4)22(5)11-13-6-8-24-9-7-13/h10,13H,6-9,11H2,1-5H3,(H,20,23)
|
|||
InChIKey |
OLLDWVBPHQUDHP-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Cannabinoid receptor 1 (CB1) | Target Info | Agonist | [1] |
Cannabinoid receptor 2 (CB2) | Target Info | Agonist | [1] | |
Target's Patent Info | Cannabinoid receptor 1 (CB1) | Target's Patent Info | [1] | |
Cannabinoid receptor 2 (CB2) | Target's Patent Info | [1] | ||
KEGG Pathway | Rap1 signaling pathway | |||
Neuroactive ligand-receptor interaction | ||||
Retrograde endocannabinoid signaling | ||||
Panther Pathway | Endogenous cannabinoid signaling | |||
Pathway Interaction Database | N-cadherin signaling events | |||
Reactome | Class A/1 (Rhodopsin-like receptors) | |||
G alpha (i) signalling events | ||||
WikiPathways | GPCRs, Class A Rhodopsin-like | |||
Small Ligand GPCRs | ||||
BDNF signaling pathway | ||||
GPCR ligand binding | ||||
GPCR downstream signaling | ||||
GPCRs, Other |
References | Top | |||
---|---|---|---|---|
REF 1 | Cannabinoid receptor 2 (CB2) agonists and antagonists: a patent update.Expert Opin Ther Pat. 2016 Jul;26(7):843-56. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.